果糖与前列腺癌:癌症细胞代谢的综合视角
本文综述了己糖(尤其是果糖)在前列腺癌中的转运与代谢。文章指出前列腺癌细胞Glut-1表达低且FDG-PET应用受限,但实验证据表明前列腺癌细胞在体外和体内可能具有增强的果糖转运和代谢能力;果糖摄取与代谢通过从头脂肪生成途径可能为前列腺癌的早期诊断、分期和治疗提供新机会。
要点
- 前列腺癌细胞Glut-1表达低至不可测,FDG-PET临床应用受限。
- 前列腺癌细胞在体外和体内可能增强果糖转运与代谢能力。
- 果糖代谢经从头脂肪生成途径或为早期诊断、分期和治疗提供机会。
核心结论
- 前列腺癌细胞可能具有增强的果糖转运和代谢能力,果糖代谢经从头脂肪生成途径或为前列腺癌诊疗提供新机会。
研究设计与样本
- 综述文章,总结己糖(尤其是果糖)在前列腺癌中转运与代谢的现有知识,并汇总体外和体内实验证据。
主要发现
- 相当数量癌症(包括前列腺癌)表达低至不可测水平的Glut-1,FDG-PET在前列腺癌中临床适用性有限。
- 实验证据表明前列腺癌细胞在体外和体内可能具有增强的果糖转运和代谢能力。
- 果糖摄取与代谢通过从头脂肪生成途径可能为前列腺癌早期诊断、分期和治疗提供新机会。
临床怎么用
- 关注果糖代谢与从头脂肪生成途径作为前列腺癌早期诊断、分期和治疗的潜在新靶点。
局限性
- 文中提及的果糖转运与代谢增强等假设尚未在前列腺癌中被批判性检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activation of glucose transporter-1 (Glut-1) gene expression is a molecular feature of cancer cells that increases glucose uptake and metabolism. Increased glucose uptake is the basis for the clinical localization of primary tumors using positron emission tomography (PET) and 2-deoxy-2-[18F]-fluoro-D-glucose (FDG) as a radiotracer. However, previous studies have demonstrated that a considerable number of cancers, which include prostate cancer (CaP), express low to undetectable levels of Glut-1 and that FDG-PET has limited clinical applicability in CaP. This observation could be explained by a low metabolic activity of CaP cells that may be overcome using different hexoses, such as fructose, as the preferred energy source. However, these hypotheses have not been examined critically in CaP. This review article summarizes what is currently known about transport and metabolism of hexoses, and more specifically fructose, in CaP and provides experimental evidences indicating that CaP cells may have increased capacity to transport and metabolize fructose in vitro and in vivo. Moreover, this review highlights recent findings that allow better understanding of how metabolism of fructose may regulate cancer cell proliferation and how fructose uptake and metabolism, through the de novo lipogenesis pathway, may provide new opportunities for CaP early diagnosis, staging, and treatment.
引用
- Carreño D, Corro N, Torres-Estay V, et al. Fructose and prostate cancer: toward an integrated view of cancer cell metabolism. Prostate Cancer Prostatic Dis. 2018. PMID: 30104655. doi:10.1038/s41391-018-0072-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。